H

Haemonetics Corp
D

HAE

66.060
USD
-0.08
(-0.12%)
مغلق
حجم التداول
15,120
الربح لكل سهم
4
العائد الربحي
-
P/E
26
حجم السوق
3,173,323,956
أصول ذات صلة
ABT
ABT
-0.240
(-0.18%)
131.240 USD
BDX
BDX
-0.820
(-0.48%)
171.380 USD
EW
EW
0.180
(0.24%)
74.970 USD
ISRG
ISRG
-3.15
(-0.58%)
539.50 USD
MDT
MDT
-0.250
(-0.31%)
80.670 USD
SYK
SYK
-1.79
(-0.47%)
376.66 USD
TMO
TMO
-6.77
(-1.69%)
393.52 USD
المزيد
الأخبار المقالات

العنوان: Haemonetics Corp

القطاع: Healthcare
الصناعة: Medical Devices
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, thecompany operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.